Elevance HealthvsMerck & Company

ELV and MRK stock compared: price, dividend, valuation and results, from SEC filings.

ELV

Elevance Health, Inc.

$433.93

Value $95.8B

-2.77%
ELV's page

MRK

Merck & Company, Inc.

$143.37

Value $354B

-0.75%
MRK's page

Elevance Health (ELV) has a market value of $95.8B and Merck & Company (MRK) $354B. Over the last year, with dividends, ELV moved +35.8% and MRK +58.8%. The P/E is 18.6 for ELV and 144.5 for MRK. Dividend yield: ELV 1.58%, MRK 2.37%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ELV$95.8B

    MRK$354B

    MRK is 3.7 times ELV

  • Revenue, 12 months

    ELV$202B

    MRK$67.4B

    ELV is 3.0 times MRK

  • Net income, 12 months

    ELV$5.1B

    MRK$2.5B

    ELV is 2.1 times MRK

  • Operating margin

    ELV2.7%

    MRK–

  • ROIC

    ELV5.9%

    MRK3.9%

    2.0 points apart

  • P/E

    ELV18.6

    MRK144.5

    MRK is 7.8 times ELV

  • Dividend yield

    ELV1.6%

    MRK2.4%

    0.8 points apart

  • 5-year return

    ELV+8.5%

    MRK+98.6%

    90.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ELV+8.5%

MRK+98.6%

10015020020222023202420252026
Returns by period
PeriodELVWith dividendsMRKWith dividends
1 year since November 14, 2025+35.8%Price +33.2%+58.8%Price +54.3%
3 years since November 17, 2023-1.4%-0.5% a yearPrice -6.3%+54.4%+15.6% a yearPrice +40.9%
5 years since November 16, 2021+8.5%+1.6% a yearPrice +0.8%+98.6%+14.7% a yearPrice +70.5%
10 years since November 17, 2016+261.1%+13.7% a yearPrice +214.7%+225.1%+12.5% a yearPrice +139.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ELVElevance HealthMRKMerck & Company

Valuation

ELVMRK
Valuation
Price$433.93$143.37
Market value$95.8B$354B
Enterprise value (EV)$90.8B$399B
P/E18.6144.5
P/E, 5-year median18.614.8
P/B2.17.9
EV/EBIT16.783.7
Free cash flow yield6.8%4.2%

Results and growth

ELVMRK
Results and growth
Revenue, 12 months$202B$67.4B
Net income, 12 months$5.1B$2.5B
Free cash flow, 12 months$6.5B$14.7B
Earnings per share, 12 months$23.52$0.98
Revenue growth, year on year12.5%1.3%
Revenue growth a year, past+10.3%over 5 years+9.4%over 5 years
EPS growth a year, past+7.0%over 5 years+21.2%over 5 years

Margins and returns on capital

ELVMRK
Margins and returns on capital
Gross margin89.0%71.8%
Operating margin2.7%–
Net margin2.6%3.6%
ROIC5.9%3.9%
ROE11.6%5.2%

Balance sheet

ELVMRK
Balance sheet
Cash$35.7B$9.7B
Total debt$30.8B$53.8B
Net debt / EBITDA-0.75.7
Interest cover3.8×2.4×

Dividends and buybacks

ELVMRK
Dividends and buybacks
Dividend yield1.6%2.4%
Dividend per share, 12 months$6.87$3.40
Dividend growth a year, past+12.2%over 5 years+5.8%over 5 years
Buyback yield2.7%1.4%
Shareholder yield4.3%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ELV or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Elevance Health or Merck & Company?

By market value, Merck & Company ($354B) is about 3.7 times Elevance Health ($95.8B), at today's prices.

How did ELV and MRK stock do over the last 10 years?

Since November 17, 2016, ELV's price moved +214.7% and MRK's +139.6%. With dividends: ELV +261.1% (+13.7% a year), MRK +225.1% (+12.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, ELV or MRK?

The dividend yield at today's price is 1.58% for Elevance Health and 2.37% for Merck & Company. Over the last twelve months they paid $6.87 and $3.40 per share.

What is the P/E of ELV and MRK?

At today's price, the P/E is 18.6 for ELV and 144.5 for MRK. The median of the last five years was 18.6 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Elevance Health or Merck & Company?

Over the last twelve months, the net margin was 2.6% for Elevance Health and 3.6% for Merck & Company, and the operating margin 2.7% and –. Revenue was $202B and $67.4B.

Which is the better investment, Elevance Health or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.